Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Coivas vs Ozari Health

Coivas
Graded #197

Lower grade

vs+3.5999999999999943
Ozari Health
Graded #117

Higher grade

The verdict

Ozari Health takes it — 69.8/100 to 66.2/100.

Ozari Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ozari Health is a telehealth weight-loss platform offering physician-prescribed compounded GLP-1 from licensed pharmacies — semaglutide from $86/month and tirzepatide from around $149/month, with shipping…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOzari Health +14
70
84
Dose & formulationEven
64
64
Clinical oversightCoivas +5
84
79
Labs & monitoringCoivas +2
54
52
FulfillmentCoivas +11
78
67
Contract termsOzari Health +35
20
55
Coivas · left barOzari Health · right bar

The numbers

MetricCoivasOzari Health
WeighScore66.2/10069.8/100
GradeCC
Scorecard rank#197#117
Semaglutide$149/mo (quarterly plan, compounded)$86/mo (compounded)
Tirzepatide$229/mo (quarterly plan, compounded)$149/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Coivas

Graded #197 · C

Strengths

  • All-inclusive pricing: one price covers doctor consult, prescription, shipping and support
  • Compounded semaglutide from $149/mo and tirzepatide from $229/mo on the quarterly plan
  • Names its clinical provider (Arora Health & Aesthetics, LLC) and cites USP 797 / NABP-accredited pharmacies
  • Available in all 50 states; 24/7 support; HSA/FSA eligible; money-back guarantee
  • Most patients approved in under 2 hours; refund if no provider visit or prescription occurs

Where it loses points

  • Dispensing pharmacies described only by category (503A/503B, NABP-accredited) - not named individually
  • Lower quarterly headline price requires a 3-month commitment; monthly plan costs more ($179/$289)
  • Money-back guarantee has strict adherence/verification conditions and no partial/prorated refunds
  • No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only; binding NY arbitration
Ozari Health

Graded #117 · C

Strengths

  • Very low entry pricing — compounded semaglutide from $86/month
  • LegitScript certified and operated by a named entity (Ozari LLC)
  • Board-certified physicians; meds compounded in 503A and 503B facilities
  • Shipping included in the plan price

Where it loses points

  • Doesn't clearly list which states it serves or name its pharmacies
  • Tirzepatide and higher semaglutide doses cost more than the $86 headline
  • Compounded semaglutide and tirzepatide only — no brand-name options
  • Newer, lighter web presence than established competitors

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard